Related Experiment Video
Updated: Sep 8, 2025
09:40
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
5.7K
Evaluating glioma-associated microRNA by complementation on a biological nanosensor
Zizhuo Li1, Xin Wan1, Mingming Li1
1Department of Abdominal Ultrasound, The First Affiliated Hospital of Harbin Medical University, Harbin city, Heilongjiang Province, 1, China.
Biotechnology and Applied Biochemistry
|June 13, 2022
Summary
A novel sensor detects microRNA-363, a biomarker for glioma, a type of brain tumor. This technology offers a new way to monitor glioma progression and severity using microRNA levels.
Area of Science:
- Biomedical Engineering
- Molecular Diagnostics
- Oncology
Background:
- Glioma, a brain and spinal cord tumor, originates from glial cells.
- MicroRNA-363 (miRNA-363) is a key biomarker associated with human glioma development and progression.
- Monitoring miRNA-363 levels can provide insights into glioma severity.
Purpose of the Study:
- To develop and validate an interdigitated electrode sensor for monitoring miRNA-363 levels.
- To establish a method for correlating miRNA-363 levels with glioma severity.
- To demonstrate the specificity and sensitivity of the sensor for miRNA-363 detection.
Main Methods:
- Fabrication of an interdigitated electrode sensor using photolithography.
- Surface chemical modification with gold nanoparticles and miRNA-363 complementary oligonucleotides as probes.
- Detection of miRNA-363 based on changes in the dipole moment between electrodes upon molecular interaction.
- Standardization of signal output changes to quantify miRNA-363 levels.
Main Results:
- The sensor successfully monitored miRNA-363 levels, reflecting glioma severity.
- Achieved a limit of detection of 10 fM for miRNA-363 with high linearity (R² = 0.996) in the range of 1 fM to 100 pM.
- Demonstrated high specificity, as unrelated sequences did not trigger a significant sensor response.
Conclusions:
- The developed interdigitated electrode sensor platform is effective for detecting miRNA-363 in glioma patients.
- This sensor technology provides a basis for monitoring glioma progression and can be adapted for other biomarker analyses.
- The study highlights the potential of electrochemical biosensors in cancer diagnostics.
